How much improvement in functioning is considered important by patients with active disease modifying anti-rheumatic drug refractory rheumatoid arthritis

被引：0
|
作者：
Singh, A [1 ]
Sato, R [1 ]
Wanke, L [1 ]
机构：
[1] Hlth Outcomes Assessment, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [31] Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
    Giachi, Andrea
    Cugno, Massimo
    Gualtierotti, Roberta
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [32] THE IMPACT OF EDUCATION ON ADHERENCE TO TREATMENT WITH DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS PATIENTS
    Holc, I.
    Pahor, A.
    Gradisnik, S.
    Dai, K.
    Krajnc, M. Koren
    Grobelsek, V. Kovacic
    Dobnik, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 706 - 707
  • [33] Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis
    Mok, MY
    Ng, WL
    Yuen, MF
    Wong, RWS
    Lau, CS
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (03) : 363 - 368
  • [34] Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis
    Haibel, H.
    Specker, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S159 - S163
  • [35] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [36] Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review
    Giollo, Alessandro
    Bissell, Lesley-Anne
    Buch, Maya H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) : 697 - 708
  • [37] Persistence on Disease Modifying Anti-Rheumatic Drugs Among Taiwan Established Rheumatoid Arthritis Patients
    Liu, Yi-Han
    Lin, Tzu-Chieh
    Yang, Yea-Huei Kao
    Chang, Hui-Jen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 73 - 73
  • [38] Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Monchablon, Clelia
    Gonde, Henri
    Pouplin, Sophie
    Varin, Remi
    Vittecoq, Olivier
    Lequerre, Thierry
    CLINICAL RHEUMATOLOGY, 2020, 39 (01) : 207 - 216
  • [39] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [40] The anti-rheumatic effect of multiple synovectomy in patients with refractory rheumatoid arthritis
    H. Nakamura
    M. Nagashima
    S. Ishigami
    K. Wauke
    S. Yoshino
    International Orthopaedics, 2000, 24 : 242 - 245
12345